Randomised Placebo-Controlled Trial of Dietary Glutamine Supplements for Postinfectious Irritable Bowel Syndrome. Gut , vol
doi: 10.1126/scitranslmed.abf5473 53 ZhuoCRuanQZhaoXShenYLinR
In vitro and in vivo toxicity assessment of the senotherapeutic Peptide 14 Type of study: non-rct in vitro Number of citations: 6 Year: 2022 Authors: Alessandra Zonari, L
Thnh phn chnh ca vin ung sng da Garivin Vin ung sng da Garivin L-Glutathione 500mg cha thnh phn chnh l L-Glutathione mt cht chng oxy ha mnh m c kh nng bo v t bo khi s tn cng ca cc gc t do, ng thi h tr qu trnh lm trng da
Kano, A., Iwasaki, T
A meta-analysis of seven SURPASS clinical trials in participants with T2DM showed the hazard ratios comparing tirzepatide versus controls of 0.80 (95% CI, 0.57 1.11) for 4-MACE, 0.90 (95% CI, 0.50 1.61) for cardiovascular death, and 0.80 (95% CI, 0.51 1.25) for all-cause mortality (264)